May 8, 2017 / 8:07 PM / 3 months ago

BRIEF-Cellular Biomedicine Q1 net loss per share $0.43

1 Min Read

May 8 (Reuters) - Cellular Biomedicine Group Inc:

* Cellular Biomedicine Group reports first quarter 2017 financial results and provides business highlights

* Cellular Biomedicine Group Inc - qtrly net loss per share $ 0.43

* Cellular Biomedicine Group Inc - cash and cash equivalents as of march 31, 2017 were $33.4 million compared to $39.3 million as of December 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below